© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 68.24% of MNMD shares are held by financial institutions. HUNTINGTON NATIONAL BANK is the top corporate investor, holding 1 shares valued at $1.00. A 0% stake in Mind Medicine (MindMed) Inc. is owned by the company. HUNTINGTON NATIONAL BANK owns 1 shares valued at $1.00, which translates its holding of 0% of the stake in the company.
Among the MNMD insiders holding of 0.7% of the stake in company, BARROW ROBERT, Chief Executive Officer, holds the largest shares of 526.67K. KARLIN DAN, Chief Medical Officer, is the second largest MNMD insider with ownership of 338.01K shares. GREENWAY SCHOND L., Chief Financial Officer, stands third with possession of 216.62K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own MNMD shares is 212, representing 68.24% of the company's common stock.
N/A, in the last quarter, reduced its stake in MNMD by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the MNMD shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned MNMD shares holding by N/A last quarter which brought its holding to - shares worth -.
As per its latest 13F filing, N/A increased its stake in MNMD by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of MNMD to its portfolio, raising its holding to - shares of worth -. N/A also increased its MNMD shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in MNMD is Barrow Robert , Chief Executive Officer at the company. Additionally, MNMD stock is highly held by Chief Medical Officer Karlin Dan and Chief Financial Officer Greenway Schond L. among others.
Company executives, directors, and other insiders own 0.7% percent of Mind Medicine (MindMed) Inc.'s stock. Within the last six months, there have been 8 transaction(s) in which MNMD insiders have sold stock, totaling 65.97K shares. Insiders that have sold shares include SULLIVAN MARK, KARLIN DAN, and LIAO CARRIE.
There have been 4 transaction(s) during the past 6-months in which Mind Medicine (MindMed) Inc. insiders have bought stock, totalling 7000 shares
Around 3.47M Mind Medicine (MindMed) Inc. shares are held by insiders, which represents about 0.7% of MNMD stock.
MNMD Chief Executive Officer, Barrow Robert holds the largest portfolio of the company's shares. MNMD shares owned by Barrow total nearly 526.67 thousand.
HUNTINGTON NATIONAL BANK is the largest institutional owner in MNMD which holds 1 shares worth $1.00 or 0% of the total MNMD shares outstanding followed by HUNTINGTON NATIONAL BANK with ownership of 1 shares representing 0% of the MNMD ownership. HUNTINGTON NATIONAL BANK is the third largest stakeholder with 1 shares or 0% of the ownership worth more than $1.00.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the MNMD is concerned, it is a stock which is optionable.
Number of MNMD shares short is 9.98M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 73.33M shares of MNMD are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, MNMD has 59.34M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for MNMD is 8.83.